ResearcherMontefiore Medical CenterNo recent work listed

Justin Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6658-2558; OpenAlex author ID A5101551803. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 trial

Papers 1

The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Co-author DOI 10.1007/s12029-019-00316-8 ↗

Trials 1

Nutrition and Pharmacological Algorithm for Oncology Patients Study Principal investigator NCT04155008 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jennifer W. Chuy · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Michael Shusterman · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Andreas Kaubisch · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Sanjay Goel · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.